Celeste Leigh Pearce, Ph.D., M.P.H.
- Associate Chair and Associate Professor, Epidemiology
- 4642 SPH Tower
- 1415 Washington Heights
- Ann Arbor, Michigan 48109-2029
Associate Professor, Department of Epidemiology, University of Michigan School of Public Health, September 2014-present Adjunct Professor, Department of Preventive Medicine, University of Southern California School of Medicine, September 2014-present Assistant Professor, Department of Preventive Medicine, University of Southern California School of Medicine, July 2008-August 2014
- Ph.D., , University of Southern California, 2003
- M.P.H., , University of Michigan, 1995
Research Interests & Projects
- Etiology and Prevention of Ovarian and Breast Cancers
- Pearce, C.L., Rossing, M.A., Lee, A.W., Ness, R.B., Webb, P.M., for Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, et. al. (2013). Combined and Interactive Effects of Environmental and GWAS- Identified Risk Factors in Ovarian Cancer. Cancer Epidemiology, Biomarkers and Prevention 880-90.
- Shen, H., Fridley, B.L., Song, H., Lawrenson, K., Cunningham, J.M., Ramus, S.J., Cicek, M.S., Tyrer, J., Stram, D., Larson, M.C., Köbel, M.; PRACTICAL Consortium,... Pharoah, P.D., Laird, P.W., Goode, E.L., Pearce, C.L.. (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications 1628.
- Hovanessian-Larsen, L., Taylor, D., Spicer, D.V., Press, M.F., Wu, A.W., Pike, M.C., Pearce, C.L. (2012). Lowering oral contraceptive norethrindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception 238-43.
- Pearce, C.L., Templeman, C., Rossing, M.A., Lee, A., Near, A.M., Webb, P.M., Nagle, C.M., Doherty, J.A., et. al. (2012). Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies The Lancet Oncology 385-94.
- Campan, M., Moffitt, M., Houshdaran, S., Shen, H., Widschwendter, M., Daxenbichler, G., Long, T., Marth, C., Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman LD, Berchuck A, Pearce, C.L., Laird, P.W. (2011). Genome-scale screen for DNA methylation-based detection markers for ovarian cancer PLoS One e28141.
Primary Collaborators: Malcolm C. Pike, PhD, Memorial Sloan Kettering Cancer Center Georgia Chenevix-Trench, PhD, Queensland Institute for Medical Research Paul DP Pharoah, MD, PhD, University of Cambridge Anna Wu, PhD, University of Southern California Andrew Berchuck, MD, Duke University David Huntsman, MD, University of British Columbia Peter Laird, PhD, Van Andel Research Institute Hui Shen, PhD, Van Andel Research Institute Claire Templeman, MD, University of Southern California Doerthe Brueggmann, MD, University of Southern California Lynda Roman, MD, University of Southern California Jessica McAlpine, MD, University of British Columbia